Revenio Group Corporation: Managers' Transactions - Riad Sherif
Person subject to the notification requirement
Name: Riad Sherif
Position: Member of the Board/Deputy member
Issuer: Revenio Group Oyj
LEI: 743700I27E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 31333/7/6
Transaction date: 2023-05-11
Outside a trading venue
Instrument type: SHARE
ISIN: FI0009010912
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details (1):
Volume: 399 Unit price: 0 EUR
Aggregated transactions (1):
Volume: 399 Volume weighted average price: 0 EUR
For further information, please contact
CFO Robin Pulkkinen, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
Distribution
Nasdaq Helsinki
FIN-FSA
Key media
www.reveniogroup.fi
Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
In 2022, the Group’s net sales totaled EUR 97.0 million, with an operating profit of EUR 29.7 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
REVENIO GROUP OYJ 
